Publications by authors named "Mark S Soloway"

Claim this Profile
I
Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group.
Roger Li, Patrick J Hensley, Marko Babjuk, Laura Bukavina, Sarah P Psutka, Mark S Soloway

Eur Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Commentary.
Mark S Soloway

Urol Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Recurrence Risk, Metastatic Potential, and Length of Cystoscopic Surveillance of Low-Grade Nonmuscle-Invasive Bladder Cancer.
Eunice Villegas, Katherine Lajkosz, Shayan Din, Cynthia Kuk, Amy Chan, Mark S Soloway

J Urol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG).
Roberto Contieri, Mark S Soloway, Paolo Gontero, Harry Herr, Wassim Kassouf

Eur Urol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Commentary.
Mark S Soloway

Urol Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 33.
Mark S Soloway, Neil A Abrahams, Nat Pinnar

Bladder Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Commentary.
Mark S Soloway

Urol Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 32.
Mark S Soloway, Neil A Abrahams

Bladder Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcomes and cost savings of office fulguration of papillary Ta low-grade bladder cancer.
Christian Vitug, Katherine Lajkosz, Julian Chavarriaga, Andres Llano, Shayan Din, Mark S Soloway

BJU Int· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 31: LG Ta Bladder Cancer.
Mark S Soloway, Neil A Abrahams

Bladder Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Mark S Soloway

Urol Pract· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 30: Rare Complication of BCG.
Mark S Soloway

Bladder Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflection points in urology as witnessed by Mark Soloway Part 2: Prostate and kidney cancers.
Mark S Soloway

Cent European J Urol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial Comment.
Mark S Soloway

Urol Pract· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflection points in urology as witnessed by Mark Soloway. Part 1: bladder cancer.
Mark S Soloway

Cent European J Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 29.
Mark S Soloway

Bladder Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 28: Lynch Syndrome.
Mark S Soloway

Bladder Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 27.
Mark S Soloway, Neil A Abrahams

Bladder Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 26.
Mark S Soloway

Bladder Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting hyaluronic acid synthase-3 (HAS3) for the treatment of advanced renal cell carcinoma.
Jiaojiao Wang, Andre R Jordan, Huabin Zhu, Sarrah L Hasanali, Eric Thomas, Mark S Soloway

Cancer Cell Int· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 25.
Mark S Soloway, Neil A Abrahams

Bladder Cancer· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 24.
Mark S Soloway, Neil A Abrahams

Bladder Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 23.
Mark S Soloway, Neil A Abrahams

Bladder Cancer· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse large B-cell lymphoma presenting as LUTS: Clinical practice points.
Soum D Lokeshwar, Syed N Rahman, Jamil Syed, Thomas F Monaghan, Benjamin Press, Mark S Soloway

Urol Case Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenging Cases in Urothelial Cancer: Case 22.
Mark S Soloway

Bladder Cancer· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis